Arnouk et al. first established Cornulin as a biomarker for cervical cancer progression from its premalignant lesions in a clinical proteomics study using a combination of laser capture microdissection and two-dimensional difference gel electrophoresis (2D DIGE). This evidence concerns the gene CRNN and cervical cancer.